(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Invasive Breast Cancer|Estrogen-receptor-positive Breast Cancer|HER2-negative Breast Cancer
Interventions: DRUG: (Z)-endoxifen|DRUG: exemestane|DRUG: goserelin
Sponsor: Atossa Therapeutics, Inc.
Collaborators: InClin